RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/22326953http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/22326953http://www.w3.org/2000/01/rdf-schema#comment"Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults. Long-term survival of patients with AML has changed little over the past decade, necessitating the identification and validation of new AML targets. Integration of genomic approaches with small-molecule and genetically based high-throughput screening holds the promise of improved discovery of candidate targets for cancer therapy. Here, we identified a role for glycogen synthase kinase 3α (GSK-3α) in AML by performing 2 independent small-molecule library screens and an shRNA screen for perturbations that induced a differentiation expression signature in AML cells. GSK-3 is a serine-threonine kinase involved in diverse cellular processes, including differentiation, signal transduction, cell cycle regulation, and proliferation. We demonstrated that specific loss of GSK-3α induced differentiation in AML by multiple measurements, including induction of gene expression signatures, morphological changes, and cell surface markers consistent with myeloid maturation. GSK-3α-specific suppression also led to impaired growth and proliferation in vitro, induction of apoptosis, loss of colony formation in methylcellulose, and anti-AML activity in vivo. Although the role of GSK-3β has been well studied in cancer development, these studies support a role for GSK-3α in AML."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.org/dc/terms/identifier"doi:10.1172/jci46465"xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Tolliday N."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Ross L."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Li L.S."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Kung A.L."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Hahn W.C."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Aster J.C."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Chow K.T."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Galinsky I."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Stone R.M."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"DeAngelo D.J."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Ross K.N."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Roti G."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Schinzel A.C."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Alexe G."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Stegmaier K."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Hahn C.K."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Kakoza R.M."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Banerji V."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Frumm S.M."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/author"Inguilizian H."xsd:string
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/date"2012"xsd:gYear
http://purl.uniprot.org/citations/22326953http://purl.uniprot.org/core/name"J Clin Invest"xsd:string